Routine delivery of artemisinin-based combination treatment at fixed health facilities reduces malaria prevalence in Tanzania: An observational study

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Khatib, Rashid A ^a,b   Skarbinski, Jacek ^c   Njau, Joseph D ^a,d   Goodman, Catherine A ^e,f   Elling, Berty F ^a,g   Kahigwa, Elizeus ^a,h   Roberts, Jacquelin M ^c   MacArthur, John R ^c   Gutman, Julie R ^c   Kabanywanyi, Abdunoor M ^a,b   Smith, Ernest E ^c   Somi, Masha F ⁱ   Lyimo, Thomas ^a   Mwita, Alex ^j   Genton, Blaise ^b   Tanner, Marcel ^b   Mills, Anne ^f   Mshinda, Hassan ^k   Bloland, Peter B ^c   Abdulla, Salim M ^a   Kachur, S Patrick ^a,c   more..

^a Ifakara Health Institutce ^*  (Tanzania)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d EMORY UNIVERSITY   (United States)

^e KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^g KAROLINSKA INSTITUTE   (Sweden)

^h Swiss Development Cooperation   (Tanzania)

ⁱ AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^j MINISTRY OF HEALTH AND SOCIAL WELFARE   (Tanzania)

^k Tanzania Commission on Science and Technology   (Tanzania)

more..

Author keywords

Artemisinin based combination therapy; Malaria; Transmission reduction

Indexed keywords

ARTEMISININ; ARTESUNATE; PYRIMETHAMINE PLUS SULFADOXINE;

ADOLESCENT; ARTICLE; CASE MANAGEMENT; CHILD; DISEASE TRANSMISSION; DRUG EFFICACY; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HUMAN; INFANT; MALARIA; MALARIA FALCIPARUM; MICROSCOPY; MONOTHERAPY; OBSERVATIONAL STUDY; PATHOGEN CLEARANCE; PRESCHOOL CHILD; PREVALENCE; REINFECTION; SCHOOL CHILD; TANZANIA;

ADOLESCENT; ADULT; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; HEALTH FACILITIES; HEALTH SERVICES RESEARCH; HUMANS; INFANT; MALARIA, FALCIPARUM; PARASITEMIA; PREVALENCE; PYRIMETHAMINE; SULFADOXINE; TANZANIA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84862197422     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-140     Document Type: Article

References (50)

1. World Health Organization, World Malaria Report, 2009 Geneva: World Health Organization 2010
2. Roll back Malaria Partnership, Global Malaria Action Plan Geneva: Roll Back Malaria Partnership 2008
3. Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short-lived reduction in infectiousness for mosquitoes. Drakeley CJ, Jawara M, Targett GA, Walraven G, Obisike U, Coleman R, Pinder M, Sutherland CJ, Trop Med Int Health 2004 9 53 61 10.1046/j.1365-3156.2003.01169.x 14728607 (Pubitemid 38178012)
4. A randomized open-label trial of artesunate- sulfadoxine-pyrimethamine with or without primaquine for elimination of sub-microscopic P. falciparum parasitaemia and gametocyte carriage in eastern Sudan. El-Sayed B, El-Zaki SE, Babiker H, Gadalla N, Ageep T, Mansour F, Baraka O, Milligan P, Babiker A, PLoS One 2007 2 1311 10.1371/journal.pone.0001311 18074034 (Pubitemid 351802583)
5. Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes. Hallett RL, Sutherland CJ, Alexander N, Ord R, Jawara M, Drakeley CJ, Pinder M, Walraven G, Targett GA, Alloueche A, Antimicrob Agents Chemother 2004 48 3940 3943 10.1128/AAC.48.10. 3940-3943.2004 15388456 (Pubitemid 39304625)
6. Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials. Okell LC, Drakeley CJ, Ghani AC, Bousema T, Sutherland CJ, Malar J 2008 7 125 10.1186/1475-2875-7-125 18613962
7. Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether. Sutherland CJ, Ord R, Dunyo S, Jawara M, Drakeley CJ, Alexander N, Coleman R, Pinder M, Walraven G, Targett GA, PLoS Med 2005 2 92 10.1371/journal.pmed.0020092 15839740 (Pubitemid 40721079)
8. Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity. Stepniewska K, Price RN, Sutherland CJ, Drakeley CJ, von Seidlein L, Nosten F, White NJ, Malar J 2008 7 249 10.1186/1475-2875-7-249 19055751
9. Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity. Okell LC, Drakeley CJ, Bousema T, Whitty CJ, Ghani AC, PLoS Med 2008 5 226 discussion e226 10.1371/journal.pmed. 0050226 19067479
10. Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. Bhattarai A, Ali AS, Kachur SP, Martensson A, Abbas AK, Khatib R, Al-Mafazy AW, Ramsan M, Rotllant G, Gerstenmaier JF, Molteni F, Abdulla S, Montgomery SM, Kaneko A, Bjorkman A, PLoS Med 2007 4 309 10.1371/journal.pmed.0040309 17988171 (Pubitemid 350220531)
11. Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia. Barnes KI, Chanda P, Ab Barnabas G, Malar J 2009 8 Suppl 1 8 10.1186/1475-2875-8-S1-S8 19917078
12. Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. Barnes KI, Durrheim DN, Little F, Jackson A, Mehta U, Allen E, Dlamini SS, Tsoka J, Bredenkamp B, Mthembu DJ, White NJ, Sharp BL, PLoS Med 2005 2 330 10.1371/journal.pmed.0020330 16187798 (Pubitemid 41735780)
13. Marked increase in child survival after four years of intensive malaria control. Kleinschmidt I, Schwabe C, Benavente L, Torrez M, Ridl FC, Segura JL, Ehmer P, Nchama GN, AmJTrop Med Hyg 2009 80 882 888
14. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Nosten F, van Vugt M, Price R, Luxemburger C, Thway KL, Brockman A, McGready R, ter Kuile F, Looareesuwan S, White NJ, Lancet 2000 356 297 302 10.1016/S0140-6736(00)02505-8 11071185 (Pubitemid 30459588)
15. Malaria control in Vietnam: the Binh Thuan experience. Van Nam N, de Vries PJ, Van Toi L, Nagelkerke N, Trop Med Int Health 2005 10 357 365 10.1111/j.1365-3156.2005.01387.x 15807800 (Pubitemid 40569255)
16. The entomological inoculation rate and Plasmodium falciparum infection in African children. Smith DL, Dushoff J, Snow RW, Hay SI, Nature 2005 438 492 495 10.1038/nature04024 16306991 (Pubitemid 41742019)
17. Measuring malaria endemicity from intense to interrupted transmission. Hay SI, Smith DL, Snow RW, Lancet Infect Dis 2008 8 369 378 10.1016/S1473- 3099(08)70069-0 18387849
18. Re.: Complex, and large, trials of pragmatic malaria interventions. Kachur SP, Abdulla S, Barnes K, Mshinda H, Durrheim D, Kitua A, Bloland P, Trop Med Int Health 2001 6 324 325 10.1046/j.1365-3156.2001.0719a.x 11348524 (Pubitemid 32385859)
19. The plausibility design, quasi-experiments and real world research: a case study of artemisinin-based combination therapy in Tanzania. Kachur SP, Evidence, Ethos and Ethnography: The Anthropology and History of Medical Research in Africa London: Berghan, Geissler PW, Molyneux S, 2010 in press
20. Ifakara DSS, Tanzania. Schellenberg J, Mukasa O, Abdulla S, Marchant T, Lengeler C, Kikumbih N, Mshinda H, Nathan R, In Population and health in developing countries. Edited by International Development Research Centre (Canada), INDEPTH Network Ottawa: International Development Research Centre 2002 159 164
21. Rufiji DSS, Tanzania. Mwageni E, Momburi D, Juma Z, Irema M, Masanja H, TEHIP and AMMP Teams, In Population and health in developing countries. Edited by International Development Research Centre (Canada), INDEPTH Network Ottawa: International Development Research Centre 2002 175 181
22. KINET: a social marketing programme of treated nets and net treatment for malaria control in Tanzania, with evaluation of child health and long-term survival. Schellenberg JR, Abdulla S, Minja H, Nathan R, Mukasa O, Marchant T, Mponda H, Kikumbih N, Lyimo E, Manchester T, Tanner M, Lengeler C, Trans R Soc Trop Med Hyg 1999 93 225 231 10.1016/S0035-9203(99)90001-9 10492745 (Pubitemid 29348807)
23. Household ownership and use of insecticide treated nets among target groups after implementation of a national voucher programme in the United Republic of Tanzania: plausibility study using three annual cross sectional household surveys. Hanson K, Marchant T, Nathan R, Mponda H, Jones C, Bruce J, Mshinda H, Schellenberg JA, BMJ 2009 339 2434 10.1136/bmj.b2434 19574316
24. Creating an "enabling environment" for taking insecticide treated nets to national scale: the Tanzanian experience. Magesa SM, Lengeler C, deSavigny D, Miller JE, Njau RJ, Kramer K, Kitua A, Mwita A, Malar J 2005 4 34 10.1186/1475-2875-4-34 16042780 (Pubitemid 41214950)
25. Markets, voucher subsidies and free nets combine to achieve high bed net coverage in rural Tanzania. Khatib RA, Killeen GF, Abdulla SM, Kahigwa E, McElroy PD, Gerrets RP, Mshinda H, Mwita A, Kachur SP, Malar J 2008 7 98 10.1186/1475-2875-7-98 18518956 (Pubitemid 351826855)
26. Assessing the validity of health facility-based data on insecticide-treated bednet possession and use: comparison of data collected via health facility and household surveys-Lindi region and Rufiji district, Tanzania, 2005. Skarbinski J, Winston CA, Massaga JJ, Kachur SP, Rowe AK, Trop Med Int Health 2008 13 396 405 10.1111/j.1365-3156.2008.02014.x 18397401 (Pubitemid 351501549)
27. Effectiveness and cost of facility-based Integrated Management of Childhood Illness (IMCI) in Tanzania. Armstrong-Schellenberg JR, Adam T, Mshinda H, Masanja H, Kabadi G, Mukasa O, John T, Charles S, Nathan R, Wilczynska K, Mgalula L, Mbuya C, Mswia R, Manzi F, de Savigny D, Schellenberg D, Victora C, Lancet 2004 364 1583 1594 10.1016/S0140-6736(04)17311-X 15519628 (Pubitemid 39446382)
28. Understanding and improving access to prompt and effective malaria treatment and care in rural Tanzania: the ACCESS Programme. Hetzel MW, Iteba N, Makemba A, Mshana C, Lengeler C, Obrist B, Schulze A, Nathan R, Dillip A, Alba S, Mayumana I, Khatib RA, Njau JD, Mshinda H, Malar J 2007 6 83 10.1186/1475-2875-6-83 17603898 (Pubitemid 47091875)
29. Obstacles to prompt and effective malaria treatment lead to low community-coverage in two rural districts of Tanzania. Hetzel MW, Obrist B, Lengeler C, Msechu JJ, Nathan R, Dillip A, Makemba AM, Mshana C, Schulze A, Mshinda H, BMC Publ Health 2008 8 317 10.1186/1471-2458-8-317
30. Improvements in access to malaria treatment in Tanzania following community, retail sector and health facility interventions-a user perspective. Alba S, Dillip A, Hetzel MW, Mayumana I, Mshana C, Makemba A, Alexander M, Obrist B, Schulze A, Kessy F, Mshinda H, Lengeler C, Malar J 2010 9 163 10.1186/1475-2875-9-163 20550653
31. Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets-a provider perspective. Alba S, Hetzel MW, Goodman C, Dillip A, Liana J, Mshinda H, Lengeler C, Malar J 2010 9 164 10.1186/1475-2875-9-164 20550654
32. National Malaria Control Program, Ministry of Health: Malaria Treatment Guidelines Dar-es-Salaam: Ministry of Health 2000
33. Artesunate combinations for treatment of malaria: meta-analysis. Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N, Lancet 2004 363 9 17 14723987 (Pubitemid 38076919)
34. Adherence to antimalarial combination therapy with sulfadoxine- pyrimethamine and artesunate in rural Tanzania. Kachur SP, Khatib RA, Kaizer E, Fox SS, Abdulla SM, Bloland PB, AmJTrop Med Hyg 2004 71 715 722 (Pubitemid 40075619)
35. Malaria Indicator Survey: Basic Documentation for Survey Design and Implementation. http://www.rollbackmalaria.org/mechanisms/merg.html#MIS
36. Prevalence of malaria parasitemia among clients seeking treatment for fever or malaria at drug stores in rural Tanzania 2004. Kachur SP, Schulden J, Goodman CA, Kassala H, Elling BF, Khatib RA, Causer LM, Mkikima S, Abdulla S, Bloland PB, Trop Med Int Health 2006 11 441 451 10.1111/j.1365-3156.2006.01588.x 16553927
37. World Health Organization, Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria Geneva: World Health Organization 2003
38. World Health Organization, Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas of intense transmission Geneva: World Health Organization 1996
39. Fever treatment and household wealth: the challenge posed for rolling out combination therapy for malaria. Njau JD, Goodman C, Kachur SP, Palmer N, Khatib RA, Abdulla S, Mills A, Bloland P, Trop Med Int Health 2006 11 299 313 10.1111/j.1365-3156.2006.01569.x 16553910 (Pubitemid 43357053)
40. Drug coverage in treatment of malaria and the consequences for resistance evolution-evidence from the use of sulphadoxine/pyrimethamine. Malisa AL, Pearce RJ, Abdulla S, Mshinda H, Kachur PS, Bloland P, Roper C, Malar J 2010 9 190 10.1186/1475-2875-9-190 20602754
41. Drug dispensing practices during implementation of artemisinin-based combination therapy at health facilities in rural Tanzania, 2002-2005. Thwing JI, Njau JD, Goodman C, Munkondya J, Kahigwa E, Bloland PB, Mkikima S, Mills A, Abdulla S, Kachur SP, Trop Med Int Health 2010 16 272 279
42. Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania. Kabanywanyi AM, Mwita A, Sumari D, Mandike R, Mugittu K, Abdulla S, Malar J 2007 6 146 10.1186/1475-2875-6-146 17996121
43. Therapeutic efficacy of sulfadoxine-pyrimethamine and amodiaquine among children with uncomplicated Plasmodium falciparum malaria in Zanzibar, Tanzania. Lemnge MM, Ali AS, Malecela EK, Sambu E, Abdulla R, Juma MS, Fakih K, Abdulla KH, Njau RJ, AmJTrop Med Hyg 2005 73 681 685 (Pubitemid 41446713)
44. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Martensson A, Stromberg J, Sisowath C, Msellem MI, Gil JP, Montgomery SM, Olliaro P, Ali AS, Bjorkman A, Clin Infect Dis 2005 41 1079 1086 10.1086/444460 16163624 (Pubitemid 41429468)
45. Efficacy of sulfadoxine-pyrimethamine in Tanzania after two years as first-line drug for uncomplicated malaria: assessment protocol and implication for treatment policy strategies. Mugittu K, Abdulla S, Falk N, Masanja H, Felger I, Mshinda H, Beck HP, Genton B, Malar J 2005 4 55 10.1186/1475-2875-4-55 16297234 (Pubitemid 41803280)
46. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance. Mugittu K, Ndejembi M, Malisa A, Lemnge M, Premji Z, Mwita A, Nkya W, Kataraihya J, Abdulla S, Beck HP, Mshinda H, AmJTrop Med Hyg 2004 71 696 702 (Pubitemid 40075616)
47. Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. Shekalaghe S, Drakeley C, Gosling R, Ndaro A, van Meegeren M, Enevold A, Alifrangis M, Mosha F, Sauerwein R, Bousema T, PLoS One 2007 2 1023 10.1371/journal.pone.0001023 17925871 (Pubitemid 351486737)
48. The addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children delays, but does not prevent treatment failure. Sutherland CJ, Drakeley CJ, Obisike U, Coleman R, Jawara M, Targett GA, Milligan P, Pinder M, Walraven G, AmJTrop Med Hyg 2003 69 19 25
49. Gametocyte clearance in uncomplicated and severe Plasmodium falciparum malaria after artesunate-mefloquine treatment in Thailand. Tangpukdee N, Krudsood S, Srivilairit S, Phophak N, Chonsawat P, Yanpanich W, Kano S, Wilairatana P, Korean J Parasitol 2008 46 65 70 10.3347/kjp.2008.46.2.65 18552540
50. Detection of low level Plasmodium falciparum gametocytes using reverse transcriptase polymerase chain reaction. Babiker HA, Abdel-Wahab A, Ahmed S, Suleiman S, Ranford-Cartwright L, Carter R, Walliker D, Mol Biochem Parasitol 1999 99 143 148 10.1016/S0166-6851(98)00175-3 10215031 (Pubitemid 29127193)